Ignite Creation Date:
2024-05-06 @ 2:42 AM
Last Modification Date:
2024-10-26 @ 11:22 AM
Study NCT ID:
NCT02109653
Status:
WITHDRAWN
Last Update Posted:
2020-11-13
First Post:
2014-03-25
Brief Title:
Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC
Sponsor:
Array Biopharma now a wholly owned subsidiary of Pfizer
Organization:
Array BioPharma
Organization Data
Organization:
Array BioPharma
Class:
INDUSTRY
Study ID:
CLGX818A2202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Array Biopharma now a wholly owned subsidiary of Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None